BIM
TARO

BlackRock Investment Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

BlackRock Investment Management’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$1.84M Buy
17,473
+1,991
+13% +$209K ﹤0.01% 2273
2016
Q3 		$1.71M Buy
15,482
+92
+0.6% +$12.2K ﹤0.01% 2278
2016
Q2 		$2.24M Buy
15,390
+8,574
+126% +$1.22M ﹤0.01% 2009
2016
Q1 		$976K Buy
6,816
+1,046
+18% +$149K ﹤0.01% 2506
2015
Q4 		$892K Buy
5,770
+5,709
+9,359% +$834K ﹤0.01% 2676
2015
Q3 		$9K Buy
+61
New +$8.53K ﹤0.01% 3738

Other funds holding TARO

Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock Investment Management's TARO Position: Q4 2016 in Review

BlackRock Investment Management increased its Taro Pharmaceutical Industries Ltd. (TARO) stake by 13% in Q4 2016, buying an estimated $209K and bringing the position to 17,473 shares worth $1.84M. The position accounts for ﹤0.01% of the portfolio, ranked #2273.

BlackRock Investment Management first reported a position in TARO in Q3 2015 and has held it in 6 quarters since. The position peaked at $2.24M in Q2 2016. 151 funds tracked by Wall St. Rank hold TARO as of Q4 2016.

  • BlackRock Investment Management held 17,473 shares of Taro Pharmaceutical Industries Ltd. worth $1.84M as of Q4 2016.
  • BlackRock Investment Management bought 1,991 Taro Pharmaceutical Industries Ltd. shares in Q4 2016, an estimated $209K.
  • Taro Pharmaceutical Industries Ltd. made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2273 holding.
  • BlackRock Investment Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q3 2015 and has held it in 6 quarters since.
  • BlackRock Investment Management's Taro Pharmaceutical Industries Ltd. position peaked at $2.24M in Q2 2016.
  • 151 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.